why choose us

First received: November 21, 2022

Clinical Trial: Humoral and Cellular Immunity Against SARS-COV-2 Vaccine in HIV-infected Patients Immunosuppressed

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: SARS-CoV-2 RNA Vaccines
HIV Infection

Study Type: Observational


Official Title: Prospective Study to Evaluate the Persistence and Characteristics of Humoral and Cellular Immunity Against SARS-COV-2 After Vaccination in HIV-infected Patients Severely Immunosuppressed

Brief Summary: Prospective, non-equality, cohort study, where investigators propose to analyze humoral and cellular immunity after two doses of SARS-CoV-2 RNA vaccines in HIV-infected participants severely immunosuppressed.A total of 92 HIV-infected subjects over 18 years old with ?200 CD4/?l (experimental group; n=46) and ? 350 CD4/?l (as control group; n=46) who have completed two doses vaccination against SARS-CoV-2 will be included in the study.Primary Objectives:To analyze the percentage of participants with…

Read more